For the year ending 2025-12-31, IVVD had $157,340K increase in cash & cash equivalents over the period. -$58,290K in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net loss | -52,489 |
| Stock-based compensation expense | 11,643 |
| Amortization of operating lease right-of-use assets | 1,352 |
| Depreciation and amortization expense | 755 |
| Other non-cash adjustments | -298 |
| Accounts receivable | 3,337 |
| Inventory | 373 |
| Prepaid expenses and other current assets | -12,924 |
| Other non-current assets | 77 |
| Accounts payable | 3,211 |
| Accrued expenses | -30,847 |
| Operating lease liabilities | -1,218 |
| Other current liabilities | 23 |
| Other non-current liabilities | 0 |
| Net cash used in operating activities | -58,135 |
| Purchases of property and equipment | 155 |
| Net cash used in investing activities | -155 |
| Proceeds from exercises of stock options | 411 |
| Proceeds from issuance of common stock under the employee stock purchase plan | 254 |
| Proceeds from at-the-market offering, net of commissions | 33,400 |
| Proceeds from underwritten public offering, net of underwriting discounts and commissions | 182,534 |
| Payments for at-the-market offering costs | 336 |
| Payments for underwritten public offering costs | 633 |
| Net cash provided by financing activities | 215,630 |
| Effect of exchange rate changes on cash and cash equivalents | 0 |
| Net increase (decrease) in cash and cash equivalents | 157,340 |
| Cash and cash equivalents at beginning of period | 69,349 |
| Cash and cash equivalents at end of period | 226,689 |
Invivyd, Inc. (IVVD)
Invivyd, Inc. (IVVD)